Your browser doesn't support javascript.
loading
Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis.
Aylon, Yael; Furth, Noa; Mallel, Giuseppe; Friedlander, Gilgi; Nataraj, Nishanth Belugali; Dong, Meng; Hassin, Ori; Zoabi, Rawan; Cohen, Benjamin; Drendel, Vanessa; Salame, Tomer Meir; Mukherjee, Saptaparna; Harpaz, Nofar; Johnson, Randy; Aulitzky, Walter E; Yarden, Yosef; Shema, Efrat; Oren, Moshe.
Afiliación
  • Aylon Y; Department of Molecular Cell Biology, The Weizmann Institute of Science, 76100, Rehovot, Israel. yael.aylon@weizmann.ac.il.
  • Furth N; Department of Immunology and Regenerative Biology, The Weizmann Institute of Science, 76100, Rehovot, Israel.
  • Mallel G; Department of Molecular Cell Biology, The Weizmann Institute of Science, 76100, Rehovot, Israel.
  • Friedlander G; Department of Life Sciences Core Facilities, The Nancy & Stephen Grand Israel National Center for Personalized Medicine (G-INCPM), The Weizmann Institute of Science, 76100, Rehovot, Israel.
  • Nataraj NB; Department of Immunology and Regenerative Biology, The Weizmann Institute of Science, 76100, Rehovot, Israel.
  • Dong M; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany.
  • Hassin O; Department of Molecular Cell Biology, The Weizmann Institute of Science, 76100, Rehovot, Israel.
  • Zoabi R; Department of Molecular Cell Biology, The Weizmann Institute of Science, 76100, Rehovot, Israel.
  • Cohen B; Department of Immunology, The Weizmann Institute of Science, 76100, Rehovot, Israel.
  • Drendel V; Department of Pathology, Robert Bosch Hospital, Stuttgart, Germany.
  • Salame TM; Flow Cytometry Unit, Department of Life Sciences Core Facilities, The Weizmann Institute of Science, 76100, Rehovot, Israel.
  • Mukherjee S; Department of Molecular Cell Biology, The Weizmann Institute of Science, 76100, Rehovot, Israel.
  • Harpaz N; Department of Immunology and Regenerative Biology, The Weizmann Institute of Science, 76100, Rehovot, Israel.
  • Johnson R; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Aulitzky WE; Department of Hematology, Oncology and Palliative Medicine, Robert Bosch Hospital, Stuttgart, Germany.
  • Yarden Y; Department of Immunology and Regenerative Biology, The Weizmann Institute of Science, 76100, Rehovot, Israel.
  • Shema E; Department of Immunology and Regenerative Biology, The Weizmann Institute of Science, 76100, Rehovot, Israel.
  • Oren M; Department of Molecular Cell Biology, The Weizmann Institute of Science, 76100, Rehovot, Israel. moshe.oren@weizmann.ac.il.
Nat Commun ; 13(1): 7199, 2022 11 28.
Article en En | MEDLINE | ID: mdl-36443319
ABSTRACT
Breast cancer, the most frequent cancer in women, is generally classified into several distinct histological and molecular subtypes. However, single-cell technologies have revealed remarkable cellular and functional heterogeneity across subtypes and even within individual breast tumors. Much of this heterogeneity is attributable to dynamic alterations in the epigenetic landscape of the cancer cells, which promote phenotypic plasticity. Such plasticity, including transition from luminal to basal-like cell identity, can promote disease aggressiveness. We now report that the tumor suppressor LATS1, whose expression is often downregulated in human breast cancer, helps maintain luminal breast cancer cell identity by reducing the chromatin accessibility of genes that are characteristic of a "basal-like" state, preventing their spurious activation. This is achieved via interaction of LATS1 with the NCOR1 nuclear corepressor and recruitment of HDAC1, driving histone H3K27 deacetylation near NCOR1-repressed "basal-like" genes. Consequently, decreased expression of LATS1 elevates the expression of such genes and facilitates slippage towards a more basal-like phenotypic identity. We propose that by enforcing rigorous silencing of repressed genes, the LATS1-NCOR1 axis maintains luminal cell identity and restricts breast cancer progression.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Israel